Brilinta 90 AstraZeneca
€310.00
What is Brilinta 90 AstraZeneca?
Brilinta, known generically as ticagrelor, is a potent antiplatelet medication developed by AstraZeneca. It is primarily used to prevent blood clots in individuals with cardiovascular conditions, such as acute coronary syndrome (ACS) or a history of heart attacks. By inhibiting platelet aggregation, Brilinta enhances cardiovascular health and reduces the risk of major adverse cardiac events. The 90 mg dosage is particularly tailored for ongoing treatment to ensure that patients maintain adequate protection against clot formation. This makes it a critical medication for those with a heightened risk of thrombotic events, especially when combined with standard therapies like aspirin.
Benefits for athletes: performance enhancement
For athletes, maintaining optimal blood flow is crucial for peak performance. Brilinta may present certain benefits that could contribute to athletic performance, although it is traditionally not seen as a performance-enhancing drug in the conventional sense. Here are some potential benefits:
- Improved circulation: By reducing the chances of clot formation, Brilinta may help maintain better blood flow, which can lead to improved oxygen delivery to muscles during intense exercise.
- Enhanced recovery: The drug’s ability to support healthy blood flow may assist in nutrient delivery and waste removal from muscles, potentially aiding in faster recovery times post-exercise.
- Increased endurance: Sustained oxygen supply during prolonged physical activity may contribute to an athlete’s endurance levels, allowing for more extended training sessions.
It’s essential to note that while Brilinta may provide these benefits, it’s primarily intended for patients with specific cardiovascular issues. Athletes should thoroughly consult with healthcare professionals before considering any use to ensure it is appropriate and safe.
How to buy Brilinta 90 AstraZeneca: reasons to trust our store
Purchasing Brilinta 90 is a process that should be approached with caution and care. For athletes and individuals looking to acquire this medication, it’s vital to buy from reputable sources. Our store offers several compelling reasons that establish trust and reliability:
- Licensed pharmacy: We operate as a fully licensed pharmacy, ensuring that all medications meet stringent safety and efficacy standards.
- Expert staff: Our team comprises experienced pharmacists who can provide guidance and answer any questions regarding the medication’s use, ensuring that you can make informed choices.
- Competitive pricing: We constantly evaluate our pricing to ensure that you receive the best possible value without compromising on quality.
- Secure transactions: Our online platform utilizes advanced encryption technologies to ensure your personal and payment information is secure.
- Customer support: We offer exceptional customer service, available to assist you with any queries or concerns that may arise before, during, and after your purchase.
By purchasing Brilinta through our store, you can be confident that you are getting a safe and effective product backed by professional support.
Side effects: medical safety
As with any medication, Brilinta also comes with potential side effects that users should be aware of. Understanding these side effects is crucial for any athlete considering the medication. Common side effects may include:
– Bleeding: One of the most significant risks associated with Brilinta is an increased likelihood of bleeding, which can manifest as bruising, prolonged bleeding from cuts, or more severe internal bleeding.
– Shortness of breath: Some users report experiencing dyspnea, which may occur in various stages of exercise or physical exertion.
– Gastrointestinal issues: Nausea and diarrhea have been noted by some individuals, potentially affecting an athlete’s nutritional status.
– Headaches: Mild to moderate headaches can occur during treatment, impacting focus and overall performance.
It is essential for athletes to engage in discussions with healthcare providers to evaluate the risks versus benefits before initiating treatment. Regular monitoring and adjusting the medication based on performance and any side effects experienced are crucial for safe usage.
How to combine Brilinta 90 AstraZeneca with other products
Combining Brilinta with other supplements or medications requires careful consideration to maximize benefits while minimizing risks. Athletes should take the following aspects into account:
- Consultation with a healthcare provider: Before making any combination, speaking with a doctor or sports nutritionist is vital to ensure compatibility with Brilinta and to avoid potential interactions.
- Timing of other supplements: Understanding when to take other supplements or medications in relation to Brilinta can assist in maximizing absorption and efficacy.
- Avoiding certain supplements: Stimulants or products that increase blood viscosity may enhance the bleeding risk associated with Brilinta and should be avoided.
- Monitoring responses: Keeping track of how your body reacts to the combination will help in making necessary adjustments to your regimen.
- Staying informed: Regularly updating your knowledge on safety guidelines and new research can aid in making informed choices about supplements.
Athletes should approach the use of Brilinta and any other products with caution and always prioritize safety and health above all else. Engaging in informed decision-making, backed by professional advice, will help ensure that performance goals are met without compromising health.
| Active substance | Ticagrelor |
|---|---|
| Acne | No |
| Water Retention | No |
| HBR | No |
| Hepatotoxicity | No |
| Aromatization | No |
| Lab Test | Not specific, may monitor platelet function tests |
| Also known as | AZD6140 |
| WAREHOUSE | International Warehouse 2 |
| Blood pressure | Can cause transient increase |
| Trade name | Brilinta, Brilique, Possia |
| Storage conditions | Store at room temperature away from moisture and heat |
| Chemical name | (1S,2S,3R,5R)-3-[7-[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropylamino]-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
| Formula | C23H28F2N6O4S |
| Substance class | Antiplatelet agent |
| Main action | Platelet aggregation inhibitor |
| Half-life | Approximately 7 to 8.5 hours |
| Dosage (medical) | Typically 90 mg twice daily |
| Dosage (sports) | Not applicable |
| Effects | Reduces the rate of stent thrombosis in patients who are at risk, decreases myocardial infarction |
| Side effects | Bleeding, dyspnea, headache, cough, hypertension, nausea |
| Use in sports | Not typically used in sports |
| Manufacturer | AstraZeneca |
| 5 |
|
0 |
| 4 |
|
0 |
| 3 |
|
0 |
| 2 |
|
0 |
| 1 |
|
0 |



Reviews
There are no reviews yet.